No implication of Simian virus 40 in pathogenesis of malignant pleural mesothelioma in Slovenia

Tumori

Volumn 96, Issue 5, 2010, Pages 667-673

  Hmeljak, Julija ^a   Kern, Izidor ^b   Cör, Andrej ^a  

^a UNIVERSITY OF PRIMORSKA   (Slovenia)

^b UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

Author keywords

Immunohistochemistry; Malignant mesothelioma; Quantitative polymerase chain reaction; Simian virus 40; Slovenia; Small t antigen

Indexed keywords

EOSIN; HEMATOXYLIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY PAB280; PARAFFIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS LARGE T ANTIGEN; VIRUS SMALL T ANTIGEN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL LINE; CONTROLLED STUDY; DNA ISOLATION; EMBEDDING; FEMALE; GOOD LABORATORY PRACTICE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MALIGNANT PLEURA MESOTHELIOMA; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PLEURA MESOTHELIOMA; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SEQUENCE HOMOLOGY; SIMIAN VIRUS 40; SLOVENIA; TISSUE SECTION; VIRAL CONTAMINATION; VIRUS DETECTION; VIRUS STRAIN;

EID: 78650455185     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089161009600504     Document Type: Article

References (33)

1. Carbone M, Albelda SM, Broaddus VC, Flores RM, Hillerdal G, Jaurand MC, Kjaerheim K, Pass HI, Robinson B, Tsao A: Eighth International Mesothelioma Interest Group. Oncogene, 26: 6959-6967, 2007. (Pubitemid 350014615)
2. Moore AJ, Parker RJ, Wiggins J: Malignant mesothelioma. Orphanet J Rare Dis, 3: 34, 2008.
3. Churg A, Roggli V, Galateau-Salle F, Cagle PhT, Gibbs AR, Hasleton PhS, Henderson DW, Vignaud JM, Inai K, Praet M, Ordonez NG, Hammar SP, Testa JR, Gazdar AF, Saracci R, Pugatch R, Samet JM, Weill H, Rusch V, Colby TV, Vogt P, Brambilla E, Travis DW: Mesothelioma. In: Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart, Travis DW, Brambilla E, Müller- Hermelink HK, Harris CC (Eds), pp. 128-136, WHO Press, Geneva, 2004.
4. [Kleihues P, Sobin LH (Series editors): WHO Classification of Tumours, Vol 10].
5. Curtone R, Lednicky J, Dunn G, Rizzo P, Bocchetta M, Chumakov K, Minor P, Carbone M: Some oral poliovirus vaccines were contaminated with infectious SV40 after 1961. Cancer Res, 65: 10273-10279, 2005.
6. Vilchez RA, Butel JS: Emergent human pathogen simian virus 40 and its role in cancer. Clin Microbiol Rev, 17: 495-508, 2004. (Pubitemid 38970679)
7. Gazdar AF, Butel JS, Carbone M: SV40 and human tumours: myth, association or causality? Nat Rev Cancer, 2: 957-964, 2002.
8. Eddy BE, Borman GS, Berkeley WH, Young RD: Tumors induced in hamsters by injection of rhesus monkey kidney cell extracts. Proc Soc Exp Biol Med, 107: 191-197, 1961.
9. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA: Creation of human tumour cells with defined genetic elements. Nature, 400: 464-468, 1999.
10. Vilchez RA, Kozinetz CA, Butel JS: Conventional epidemiology and the link between SV40 and human cancers. Lancet Oncol, 4: 188-191, 2003. (Pubitemid 36322310)
11. Hmeljak J, Cör A: Presence and role of simian virus 40 (SV40) in malignant pleural mesothelioma. Radiol Oncol, 43: 9-16, 2009.
12. Chang SE, Keen J, Lane EB, Taylor-Papadimitriou J: Establishment and characterization of SV40-transformed human breast epithelial cell lines. Cancer Res, 42: 2040-2053, 1982. (Pubitemid 12103410)
13. Shah KV: SV40 and human cancer: a review of recent data. Int J Cancer, 120: 215-223, 2006.
14. Debevec M, Kovač V, Debeljak A, Eržen J, Remškar Z, Kern I: Malignant pleural mesothelioma. Analysis of patients in Slovenia 1980-1997. Zdrav Vest-Slov Med J, 69: 599-606, 2000.
15. Lešničar J, Urlep F: Prof. dr.Mirko Jung eighty years old and still fully driven. Zdrav Vest-Slov Med J, 75: 193-208, 2006.
16. Peabody R: Polio vaccination in Europe: the shift from OPV to IPV use. Euro Surveill, 8(34): pii=2529, 2004. Available from http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId=2529 (Accessed 4 October 2010).
17. Cör A, Pižem J, Gale N: Immunohistochemical analysis of pro- and active-caspase 3 in laryngeal squamous cell carcinoma. Virchows Arch, 444: 439-446, 2004. (Pubitemid 38714046)
18. Cristaudo A, Powers A, Vivaldi A, Foddis R: SV40 can be reproducibly detected in paraffin-embedded mesothelioma samples. Anticancer Res, 20: 895-898, 2000.
19. Rozen S, Skaletsky HJ: Primer 3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology, Krawetz S,Misener S (Eds), pp 365-386, Humana Press, Totowa, New Jersey, 2000. Available from http://frodo.wi.mit.edu (Accessed 4 October 2010).
20. Lednicky JA, Butel JS: Consideration of PCR methods for the detection of SV40 in tissue and DNA specimens. Dev Biol Stand, 94: 155-164, 1998.
21. Montano X, Lane DP:Monoclonal antibody to Simian virus 40 small t. J Virol, 51: 760-767, 1984.
22. Ramael M: Causes and prevention of technical artifacts when studying simian virus 40 (SV40) in human mesotheliomas. In: Malignant Mesothelioma. Advances in Pathogenesis, Diagnosis and Translational Therapies, Pass HI, Vogelzang NJ, Carbone M (Eds), pp. 309-329, Springer Science + Business Media, New York, 2005.
23. Lopez-Rios F, Illei PB, Rusch V, Ladanyi M: Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet, 364: 1157-1166, 2004.
24. Sablina AA, Hahn WC: SV40 small T antigen and PP2A phosphatase in cell transformation. Cancer Metast Rev, 27: 137-146, 2008.
25. Shah KV, Rollison DEM: Investigation of the SV40 - human cancer association: look for the full signature of the virus. Dis Markers, 17: 159-161, 2001.
26. Carbone M, Pass HI, Rizzo P, Marinetti M, Di Muzio M, Mew DJ, Levine AS, Procopio A: Simian virus 40-like sequences in human mesothelioma. Oncogene, 9: 1781-1790, 1994.
27. Ziegler A, Seemayer CA, Hinterberger M, Vogt P, Bigosch C, Gautschid O, Tornillo L, Betticherd DC, Moch H, Stahela RA: Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results. Lung Cancer, 57: 282-291, 2007.
28. Lundstig A, Dejmek A, Eklund C, Filinic I, Dillner J: No detection of SV40 DNA in mesothelioma tissues from a high incidence area in Sweden. Anticancer Res, 27: 4159-4162, 2007.
29. Kroczynska B, Curtone R, Bocchetta M, Yang H, Elmishad AG, Vacek P, Ramos-Nino M, Mossman BT, Pass HI, Carbone M: Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and causing mesothelioma in hamsters. Proc Natl Acad Sci USA, 103: 14128-14133, 2006.
30. Elmishad AG, Bocchetta M, Pass HI, Carbone M: Polio vaccines, SV40 and human tumours, an update on false positive and false negative results. Dev Biol, 123: 109-32, 2006.
31. Poulin DL, DeCaprio JA: Is there a role for SV40 in human cancer? J Clin Oncol, 24: 4356-65, 2006.
32. Leithner K, Leithner A, Clar H, Weinnaeusel A, Radl R, Krippl P, Rehak P, Windhager R, Haas OA, Olschewski H: Mesothelioma mortality in Europe: impact of asbestos consumption and simian virus 40. Orphanet J Rare Dis, 1: 44, 2006.
33. Kovač V: Mezoteliom plevre (Mesothelioma of the pleura). In: Onkologija. Raziskovanje, diagnostika in zdravljenje raka[ Oncology. Research, diagnosis and treatment of cancer], Novaković S, Hočevar M, Jezeršek Novaković B, Strojan P, Žgajnar J (Eds), pp. 295-296, Mladinska knjiga, Ljubljana, Slovenia, 2009.